Search

Many countries employ "alternative access schemes" (e.g. compassionate use, early access programs, off-label use) that seek to provide patients with access to drugs not included on a positive drug list. These schemes offer...

Early access Off-label oncology Pharmaceutical pricing and reimbursement Rare Diseases Slovakia /dk/atira/pure/subjectarea/asjc/2700/2719 name=Health Policy /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being name=SDG 3 - Good Health and Well-being

Many countries employ "alternative access schemes" (e.g. compassionate use, early access programs, off-label use) that seek to provide patients with access to drugs not included on a positive drug list. These schemes offer...

Early access Off-label oncology Pharmaceutical pricing and reimbursement Rare Diseases Slovakia Antineoplastic Agents Compassionate Use Trials Drug Approval drugs Investigational Health Policy Humans Off-Label Use Orphan Drug Production Reimbursement Mechanisms Slovakia

Many countries employ "alternative access schemes" (e.g. compassionate use, early access programs, off-label use) that seek to provide patients with access to drugs not included on a positive drug list. These schemes offer...

Early access Off-label oncology Pharmaceutical pricing and reimbursement Rare Diseases Slovakia /dk/atira/pure/subjectarea/asjc/2700/2719 name=Health Policy /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being name=SDG 3 - Good Health and Well-being